×
Back to Agenda
Session 10 Track 3: Real-World Case Studies in Oligonucleotide CMC Development and Commercialization
Session Chair(s)
Firoz Antia, PHD
Vice President, Oligonucleotide and Small Molecule CMC, Denali Therapeutics, United States
Session 10 Track 3: Real-World Case Studies in Oligonucleotide CMC Development and Commercialization
Speaker(s)
Representative Invited
Senior Director, Regulatory Affairs CMC, Vertex Pharmaceuticals, United States
Speaker
Representative Invited
Executive Director, CMC RegulatoryAffairs, Ionis Pharmaceuticals, Inc., United States
Speaker
Have an account?